Kang, B.; Lee, S.-J.; Seol, K.H.; Jeong, Y.Y.; Choi, J.-H.; Choi, B.-H.; Ryu, J.M.; Choi, Y.S.
Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib. Int. J. Mol. Sci. 2025, 26, 2921.
https://doi.org/10.3390/ijms26072921
AMA Style
Kang B, Lee S-J, Seol KH, Jeong YY, Choi J-H, Choi B-H, Ryu JM, Choi YS.
Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib. International Journal of Molecular Sciences. 2025; 26(7):2921.
https://doi.org/10.3390/ijms26072921
Chicago/Turabian Style
Kang, Bongkyun, Sun-Jae Lee, Ki Ho Seol, Yoon Young Jeong, Jung-Hye Choi, Bo-Hyun Choi, Jung Min Ryu, and Youn Seok Choi.
2025. "Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib" International Journal of Molecular Sciences 26, no. 7: 2921.
https://doi.org/10.3390/ijms26072921
APA Style
Kang, B., Lee, S.-J., Seol, K. H., Jeong, Y. Y., Choi, J.-H., Choi, B.-H., Ryu, J. M., & Choi, Y. S.
(2025). Trabectedin Induces Synthetic Lethality via the p53-Dependent Apoptotic Pathway in Ovarian Cancer Cells Without BRCA Mutations When Used in Combination with Niraparib. International Journal of Molecular Sciences, 26(7), 2921.
https://doi.org/10.3390/ijms26072921